Sfoglia per Autore
Systemic adjuvant chemotherapy after resection of colorectal cancer metastases
2004 G. Brandi; E. Derenzini; M.A. Pantaleo; M. Di Battista; M. Ravaioli; G. Ercolani; G.L. Grazi; S. Fanello; M. Di Marco; E. Nobili; R. Hakim; R. Poggi; E. Palmerini; G. Biasco
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis.
2004 BIASCO G.; CENACCHI G; NOBILI E; PANTALEO MA; CALABRESE C; DI FEBO G; MORSELLI LABATE A; MIGLIOLI M; BRANDI G.
Spontaneous regression of a desmoid intraabdominal tumor in a patient affected by familial adenomatous polyposis.
2004 BIASCO G.; PANTALEO MA; NOBILI E; MONTI C.
THE RISK OF DUODENAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP)
2005 G. Biasco; R. Sassatelli; E. Nobili; L. Camellini; M.A. Pantaleo; G. Bertoni; C. Calabrese; A. De Vivo; G. Poggioli; M. Ponz De Leon; G. Bedogni; T. Venesio; L. Varesco; M. Risio; G. Di Febo; G. Brandi
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis.
2006 Biasco G; Nobili E; Calabrese C; Sassatelli R; Camellini L; Pantaleo MA; Bertoni G; De Vivo A; Ponz De Leon M; Poggioli G; Bedogni G; Venesio T; Varesco L; Risio M; Di Febo G; Brandi G.
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOISTITUTIONAL EXPERIENCE.
2007 Di Marco M; Nobili E; Di Cicilia R; Brandi G; Bertolini S; Derenzini E; Dell’Arte S; Casadei R; Calculli L; Biasco G.
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean
2008 G. Brandi;R Di Cicilia;M.Di Battista;E.Nobili;M.Astorino;M. Di Marco;MA Pantaleo;G.Biasco
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE
2008 M.Di Marco ;M. Macchini; R. Di Cicilia ; E. Nobili ; G. Biasco
Gemox in combination witherlotinib (E) in pancreatic cancer (PC).
2008 R. Di Cicilia;M. Macchini; M. Di Marco;E. Nobili;L.Calculli;R. Casadei; G.Biasco
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid
2008 Nobili E.; Pezzilli R.; Santini D.; Campidelli C.; Calculli L.; Casadei R.; Biasco G.
EXOCRINE-ENDOCRINE PANCREATIC CANCER AND alpha-FETOPROTEIN
2008 G. BRANDI;E. NOBILI; E.CAPIZZI;B. CORTI; R. DI CICILIA; M. DI MARCO;G. BIASCO
Nanotechnology-Related environment, health and safety Research
2009 Brandi G; Nobili E; Di Girolamo S.; Grazi GL; Fiorentino M; Golfieri G; Biasco G.
METRONOMIC CAPECITABINE IN HEPATOCELLULAR CARCINOMA RELAPSE AFTER LIVER TRANSPLANTATION: A RETROSPECTIVE STUDY
2009 F De Rosa; V Agostini; M Ravaioli; M Cescon; GL Grazi; S Di Girolamo; E Nobili; AD Pinna; G Biasco; G Brandi
IMPACT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL OF PATIENTS WITH KLATSKIN TUMOR
2009 S. Di Girolamo; V. Agostini; E. Nobili; F. De Rosa; GL. Grazi; G. Ercolani; R. Golfieri; M. Fiorentino; E. Derenzini; G. Biasco; G. Brandi
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment?
2009 Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G.
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC)
2009 Brandi, Giovanni; Paterini, Paola; Tavolari, Simona; dal Pozzo, G.; Nobili, Elisabetta; DI CICILIA, Roberto; DI MARCO, Mariacristina; Pantaleo, MARIA ABBONDANZA; DE ROSA, Francesco; Biasco, Guido
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment?
2009 Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G.
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients.
2009 Macchini M; Di Cicilia R; Vecchiarelli S; de Rosa F; Nobili E; Di Marco M; Biasco G.
The protease inhibitor gabexate Mesylate has antitumor effects and enhances gemcitabine action on pancreatic cancer cell lines
2009 Brandi G; tavolari S; Paterini P; de Rosa F; Di Girolamo S; Agostini V;Di Cicilia R;Di Marco M; Nobili E; Biasco G.
TO WIDEN THE SETTING OF CANCER PATIENTS WHO BENEFIT FROM METRONOMIC CAPECITABINE
2009 NANNINI M; NOBILI E;DI CICILIA R;BRANDI G; MALEDDU A; PANTALEO MA; BIASCO G
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Systemic adjuvant chemotherapy after resection of colorectal cancer metastases | G. Brandi; E. Derenzini; M.A. Pantaleo; M. Di Battista; M. Ravaioli; G. Ercolani; G.L.... Grazi; S. Fanello; M. Di Marco; E. Nobili; R. Hakim; R. Poggi; E. Palmerini; G. Biasco | 2004-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. | BIASCO G.; CENACCHI G; NOBILI E; PANTALEO MA; CALABRESE C; DI FEBO G; MORSELLI LABATE A; MIGLIOLI... M; BRANDI G. | 2004-01-01 | HUMAN PATHOLOGY | - | 1.01 Articolo in rivista | - |
Spontaneous regression of a desmoid intraabdominal tumor in a patient affected by familial adenomatous polyposis. | BIASCO G.; PANTALEO MA; NOBILI E; MONTI C. | 2004-01-01 | THE AMERICAN JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
THE RISK OF DUODENAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) | G. Biasco; R. Sassatelli; E. Nobili; L. Camellini; M.A. Pantaleo; G. Bertoni; C. Calabrese; A. De... Vivo; G. Poggioli; M. Ponz De Leon; G. Bedogni; T. Venesio; L. Varesco; M. Risio; G. Di Febo; G. Brandi | 2005-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. | Biasco G; Nobili E; Calabrese C; Sassatelli R; Camellini L; Pantaleo MA; Bertoni G; De Vivo A; Po...nz De Leon M; Poggioli G; Bedogni G; Venesio T; Varesco L; Risio M; Di Febo G; Brandi G. | 2006-01-01 | DISEASES OF THE COLON & RECTUM | - | 1.01 Articolo in rivista | - |
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOISTITUTIONAL EXPERIENCE. | Di Marco M; Nobili E; Di Cicilia R; Brandi G; Bertolini S; Derenzini E; Dell’Arte S; Casadei R; C...alculli L; Biasco G. | 2007-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean | G. Brandi;R Di Cicilia;M.Di Battista;E.Nobili;M.Astorino;M. Di Marco;MA Pantaleo;G.Biasco | 2008-01-01 | ANNALS OF ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE | M.Di Marco ;M. Macchini; R. Di Cicilia ; E. Nobili ; G. Biasco | 2008-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). | R. Di Cicilia;M. Macchini; M. Di Marco;E. Nobili;L.Calculli;R. Casadei; G.Biasco | 2008-01-01 | JOP. JOURNAL OF THE PANCREAS | s.n | 4.02 Riassunto (Abstract) | - |
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid | Nobili E.; Pezzilli R.; Santini D.; Campidelli C.; Calculli L.; Casadei R.; Biasco G. | 2008-01-01 | CASE REPORTS IN GASTROENTEROLOGY | - | 1.01 Articolo in rivista | crg0002-0011.pdf |
EXOCRINE-ENDOCRINE PANCREATIC CANCER AND alpha-FETOPROTEIN | G. BRANDI;E. NOBILI; E.CAPIZZI;B. CORTI; R. DI CICILIA; M. DI MARCO;G. BIASCO | 2008-01-01 | PANCREAS | - | 1.01 Articolo in rivista | - |
Nanotechnology-Related environment, health and safety Research | Brandi G; Nobili E; Di Girolamo S.; Grazi GL; Fiorentino M; Golfieri G; Biasco G. | 2009-01-01 | ENVIRONMENTAL HEALTH PERSPECTIVES | - | 1.04 Replica / breve intervento (e simili) | - |
METRONOMIC CAPECITABINE IN HEPATOCELLULAR CARCINOMA RELAPSE AFTER LIVER TRANSPLANTATION: A RETROSPECTIVE STUDY | F De Rosa; V Agostini; M Ravaioli; M Cescon; GL Grazi; S Di Girolamo; E Nobili; AD Pinna; G Biasc...o; G Brandi | 2009-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |
IMPACT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL OF PATIENTS WITH KLATSKIN TUMOR | S. Di Girolamo; V. Agostini; E. Nobili; F. De Rosa; GL. Grazi; G. Ercolani; R. Golfieri; M. Fiore...ntino; E. Derenzini; G. Biasco; G. Brandi | 2009-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? | Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G. | 2009-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) | Brandi, Giovanni; Paterini, Paola; Tavolari, Simona; dal Pozzo, G.; Nobili, Elisabetta; DI CICILI...A, Roberto; DI MARCO, Mariacristina; Pantaleo, MARIA ABBONDANZA; DE ROSA, Francesco; Biasco, Guido | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? | Di Marco M; Macchini M; Di Cicilia R; Nobili E; Biasco G. | 2009-01-01 | ANNALS OF ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. | Macchini M; Di Cicilia R; Vecchiarelli S; de Rosa F; Nobili E; Di Marco M; Biasco G. | 2009-01-01 | JOP. JOURNAL OF THE PANCREAS | - | 4.02 Riassunto (Abstract) | - |
The protease inhibitor gabexate Mesylate has antitumor effects and enhances gemcitabine action on pancreatic cancer cell lines | Brandi G; tavolari S; Paterini P; de Rosa F; Di Girolamo S; Agostini V;Di Cicilia R;Di Marco M; N...obili E; Biasco G. | 2009-01-01 | ANNALS OF ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
TO WIDEN THE SETTING OF CANCER PATIENTS WHO BENEFIT FROM METRONOMIC CAPECITABINE | NANNINI M; NOBILI E;DI CICILIA R;BRANDI G; MALEDDU A; PANTALEO MA; BIASCO G | 2009-01-01 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile